MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/js9.0000000000003242

Медицинская библиотека · International journal of surgery (London, England) · 2025

Assessing the impact of radiofrequency ablation on hilar cholangiocarcinoma: a systematic review and meta-analysis.

Zhou Haibin, Khizar Hayat, Wang Jing, Yang Jianfeng

СтатьяСистематический обзорМетаанализПеревод пока не подготовлен

Аннотация

BACKGROUND AND AIMS: Hilar cholangiocarcinoma (HC) is a challenging malignancy with limited treatment options. Radiofrequency ablation (RFA) has emerged as a potential palliative treatment, but its efficacy and safety remain controversial. This systematic review and meta-analysis aimed to evaluate the impact of RFA + stent (RFA + S) and stent only (S-only) on HC patients.

METHODS

We conducted a systematic search of PubMed, Embase, and Scopus databases for studies published up to December 2024. Eligible studies reporting RFA outcomes were included. The primary outcome was overall survival (OS). Secondary outcomes included stent patency (SP), stent dysfunction, and adverse events. We calculated hazard ratios (HR) and odds ratios (OR) using random-effects models.

RESULTS

This analysis included eleven studies ( n = 874 patients) that met the inclusion criteria. The pooled HR for OS was 0.74 (95% confidence interval [CI]: 0.61-0.89, P = 0.002), and SP was 0.77 (95% CI: 0.61-0.97; P = 0.03), showing a significant difference in favor of the RFA group. The OR of overall adverse events was 1.48 (95% CI: 0.59-3.72), cholangitis was 1.71 (95% CI: 0.78-3.75), pancreatitis was 1.03 (95% CI: 0.19-5.50), and liver abscess was 0.62 (95% CI: 0.07-5.24), showing no difference ( P > 0.05) between the two groups. Patients with chemotherapy showed better survival, indicated by an HR of 0.57 (95% CI: 0.40-0.81). Subgroup analyses also showed that randomized controlled trial (RCT) studies had no difference from non-RCT studies.

CONCLUSIONS

This meta-analysis suggests that the application of RFA offers better survival and stent patency benefits with comparable adverse events.

Для цитирования: Zhou Haibin, Khizar Hayat, Wang Jing, Yang Jianfeng. Assessing the impact of radiofrequency ablation on hilar cholangiocarcinoma: a systematic review and meta-analysis.. International journal of surgery (London, England). 2025. DOI: 10.1097/js9.0000000000003242.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.